Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
GRAP2 Antibody, Adapter protein GRID Antibody, GRAP-2 Antibody, GRB2L Antibody, Grf40 adapter protein Antibody, GRB2-related adapter protein 2 Antibody, GRBLG Antibody, Grf-40 Antibody, Grf40 Antibody, GRB2-related adaptor protein 2 Antibody, GRID Antibody, MONA Antibody, Protein GADS Antibody, SH3-SH2-SH3 adaptor molecule Antibody, SH3-SH2-SH3 adapter Mona Antibody, GADS Antibody, GRB-2-like protein Antibody, GrbX Antibody, GRPL Antibody, p38 Antibody
GRAP2 / GRID is a member of the GRB2/Sem5/Drk family. This member is an adaptor-like protein involved in leukocyte-specific protein-tyrosine kinase signaling. Like its related family member, GRB2-related adaptor protein (GRAP), this protein contains an SH2 domain flanked by two SH3 domains. This protein interacts with other proteins, such as GRB2-associated binding protein 1 (GAB1) and the SLP-76 leukocyte protein (LCP2), through its SH3 domains.
IHC of paraffin-embedded Human endometrium tissue using anti-GRAP2 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-GRAP2 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-GRAP2 mouse monoclonal antibody.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GRAP2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-GRAP2.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-GRAP2 monoclonal antibody.
Flow cytometry of Jurkat cells, using anti-GRAP2 antibody (Red), compared to a nonspecific negative control antibody (Blue).
HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-GRAP2 antibody, and then analyzed by flow cytometry.
Requested From: United States
Date Requested: 1/18/2017